Abstract:Sulfur dioxide (SO 2 ), long considered to be a harmful atmospheric pollutant, has recently been posited as the fourth gasotransmitter, as it is produced endogenously in mammals and has important pathophysiological effects. The field of tumor therapy has witnessed a paradigm shift with the emergence of SO 2 -based gas therapy. This has been possible because SO 2 is a potent glutathione consumer that can promote the production of reactive oxygen species, eventually leading to oxidative-stress-induced cancer cell death. Nevertheless, this therapeutic gas cannot be directly administrated in gaseous form. Thus, various nano formulations incorporating SO 2 donors or prodrugs capable of storing and releasing SO 2 have been developed in an attempt to achieve active/passive intratumoral accumulation and SO 2 release in the tumor microenvironment. In this review article, the advances over the past decade in nanoplatforms incorporating sulfur SO 2 prodrugs to provide controlled release of SO 2 for cancer therapy are summarized. We first describe the synthesis of polypeptide SO 2 prodrugs to overcome multiple drug resistance that was pioneered by our group, followed by other macromolecular SO 2 prodrug structures that self-assemble into nanoparticles for tumor therapy. Second, we describe nanoplatforms composed of various small-molecule SO 2 donors with endogenous or exogenous stimuli responsiveness, including thiol activated, acid-sensitive, and ultraviolet or near-infrared light-responsive SO 2 donors, which have been used for tumor inhibition. Combinations of SO 2 gas therapy with photodynamic therapy, chemotherapy, photothermal therapy, sonodynamic therapy, and nanocatalytic tumor therapy are also presented. Finally, we discuss the current limitations and challenges and the future outlook for SO 2 -based gas therapy. Statement of Significance : Gas therapy is attracting increasing attention in the scientific community because it is a highly promising strategy against cancer owing to its inherent biosafety and avoidance of drug resistance. Sulfur dioxide (SO 2 ) is recently found to be produced endogenously in mammals with important pathophysiological effects. This review summarizes recent advances in sulfur dioxide (SO 2 ) releasing nanosystems for cancer therapy, including polymeric prodrugs, endogenous or exogenous stimulus-activated SO 2 donors delivered by nanoplatform and combination therapy strategies.

A biodegradable calcium sulfite nanoreactor for pH triggered gas therapy in combination with chemotherapy

Nanotherapeutics for Hydrogen Sulfide-Involved Treatment: an Emerging Approach for Cancer Therapy

Glutathione-triggered release of SO2 gas to augment oxidative stress for enhanced chemodynamic and sonodynamic therapy

Recent Advances in Sulfur Dioxide Releasing Nanoplatforms for Cancer Therapy

Biodegradable calcium sulfide-based nanomodulators for H 2 S-boosted Ca 2+ -involved synergistic cascade cancer therapy

Sulfite‐Inserted MgAl Layered Double Hydroxides Loaded with Glucose Oxidase to Enable SO2‐Mediated Synergistic Tumor Therapy

Mesoporous Organosilica-Based Hydrogen Sulfide Nanogenerator for Enhanced Tumor Chemotherapy

Sulfite‐Inserted MgAl Layered Double Hydroxides Loaded with Glucose Oxidase to Enable SO 2 ‐Mediated Synergistic Tumor Therapy

A Tumor‐Microenvironment‐Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal‐Enhanced Enzyme Dynamic Therapy

GSH-Triggered/Photothermal-Enhanced H2S Signaling Molecule Release for Gas Therapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

An integrated ROS booster: Hydrogen sulfide-donating nanoclusters designed for multi-mode breast cancer treatment

H2S-Responsive NIR-II Fluorescent Nanozyme that Regulates Tumor Microenvironment for Activatable Synergistic CO Therapy/Catalytic Therapy/Immunotherapy

Zwitterionic Polymer Coating of Sulfur Dioxide‐Releasing Nanosystem Augments Tumor Accumulation and Treatment Efficacy

Personalized SO2 Prodrug for pH-Triggered Gas Enhancement in Anti-Tumor Radio-Immunotherapy

Photothermal‐Triggered Sulfur Oxide Gas Therapy Augments Type I Photodynamic Therapy for Potentiating Cancer Stem Cell Ablation and Inhibiting Radioresistant Tumor Recurrence

A Compartmental Silica Nanoreactor for Multienzyme‐Regulated Superactive Catalytic Therapy

Self-supply of hydrogen peroxide by a bimetal-based nanocatalytic platform to enhance chemodynamic therapy for tumor treatment

Titanium Sulfide Nanosheets Serve as Cascade Bioreactors for H2S‐Mediated Programmed Gas–Sonodynamic Cancer Therapy

Biodegradable Cascade Nanocatalysts Enable Tumor-Microenvironment Remodeling for Controllable CO Release and Targeted/synergistic Cancer Nanotherapy.

A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia